| 000 | 01186 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514051657.0 | ||
| 264 | 0 | _c20030530 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a0012-2823 | ||
| 024 | 7 |
_a10.1159/000065588 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYacyshyn, B R | |
| 245 | 0 | 0 |
_aThe clinical importance of proton pump inhibitor pharmacokinetics. _h[electronic resource] |
| 260 |
_bDigestion _c2002 |
||
| 300 |
_a67-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _a2-Pyridinylmethylsulfinylbenzimidazoles |
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aCost Savings |
| 650 | 0 | 4 |
_aDuodenal Ulcer _xdrug therapy |
| 650 | 0 | 4 |
_aGastroesophageal Reflux _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOmeprazole _xadministration & dosage |
| 650 | 0 | 4 | _aPantoprazole |
| 650 | 0 | 4 | _aProton Pump Inhibitors |
| 650 | 0 | 4 |
_aSulfoxides _xadministration & dosage |
| 700 | 1 | _aThomson, A B R | |
| 773 | 0 |
_tDigestion _gvol. 66 _gno. 2 _gp. 67-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000065588 _zAvailable from publisher's website |
| 999 |
_c12235215 _d12235215 |
||